Skip Navigation

Faculty Directory

Hemalkumar B. Mehta, PhD

  • Assistant Professor

Departmental Affiliations

  • Epidemiology (Primary)
    • Division: General Epidemiology and Methodology

Contact Information

615 N. Wolfe Street
Room E7640
Baltimore, Maryland 21205


View Current Courses


PhD, University of Houston, 2014
MS, University of Houston, 2010
BS, North Maharashtra University, 2006


Dr. Mehta is a pharmacist with expertise in pharmaceutical health outcomes research. Dr. Mehta's research interests are in pharmacoepidemiology, comparative effectiveness research and risk adjustment. Dr. Mehta uses large administrative claims, electronic medical records and national survey data to determine drug utilization patterns and safety and effectiveness of pharmaceutical interventions.

Honors and Awards


2010 Inductee, Rho Chi Honor Society University of Houston


2010 & 2011 Poster Finalist Award, 15th and 16th ISPOR annual meeting

2011 & 2012 Travel Grant and SAS Junior Professional Award, South Central SAS User’s Group (SCSUG)

2012 Travel Grant, 48th DIA annual meeting, Philadelphia, PA

2012 Travel Grant, 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), Barcelona, Spain

2014 Graduate Student Excellence Award, College of Pharmacy, University of Houston

2015 Certificate of Outstanding Contribution in Reviewing, Value in Health

2019 Top 10% reviewer, Annals of Internal Medicine

  • drug safety
  • drug effectiveness
  • pharmacoepidemiology
  • risk adjustment
  • comorbidity scores

Selected publications:

  • Mehta HB, Mehta V, Girman CJ, Adhikari D, Johnson ML. Regression coefficient-based scoring system should be used to assign weights to the risk index. J Clin Epidemiol. 2016;79:22-28.
  • Mehta HB, Yong S, Sura SD, Hughes BD, Kuo YF, Williams SB, Tyler DS, Riall TS, Goodwin JS. Development of comorbidity score for patients undergoing major surgery. Health Serv Res. 2019.
  • Jupiter DC, Fang X, Ashmore Z, Shibuya N, Mehta HB. The Relative Risk of Achilles Tendon Injury in Patients Taking Quinolones. Pharmacotherapy. 2018;38(9):878-887.
  • Williams SB, Shan Y, Ray-Zack MD, Hudgins HK, Jazzar U, Tyler DS, Freedland SJ, Swanson TA, Baillargeon JG, Hu JC, Kaul S, Kamat AM, Gore JL, Mehta HB. Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer. JAMA Surg. 2019.